Risk for febrile neutropenia was high among patients with metastases from a variety of common cancers and was associated with numerous clinical and economic consequences, including increased morbidity and mortality.
A large trial showed that treatment-emergent vasomotor and/or joint symptoms do not correlate with any improvement in recurrence-free survival in postmenopausal breast cancer patients treated with aromatase inhibitors.
At ONS Congress 2013, Peggy Scott explains how chemotherapy education classes at The Emily Couric Cancer Center, now in place for 2 years, have put patients at the center of their care and prepared them to start treatment (abstract 129532).
At ONS Congress 2013, Rebekah Clark discusses a standardized fertility-preservation education program that boosted nurse-patient discussion of fertility options from 0 to 71% and referrals for interested patients from 17% to 80% (abstract 95960).
At ONS Congress 2013, Janet Gordils-Perez, Carla Schaefer, and Jacquelyn Lauria from CINJ discuss evidence-based tools developed to support nursing assessment and effective interventions for patients with sleep-wake disturbances (abstract 120187).
At ONS Congress 2013, Bruce Grant explains how integrating a nurse-driven tobacco cessation program for newly diagnosed oncology patients, called Quit Smart, into regularly scheduled appointments boosted the long-term quit rate (abstract 136806).
In this interview, Laura Zitella will be discussing challenges and considerations for management and prevention of infection in the oncology setting—in both patients with solid tumors and those with hematologic malignancies.